An Immunogenomic Approach to Breast Cancer in Young Women

Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial

Steven David, Peter Savas, Shankar Siva, Mathias Bressel, Michelle White, Bronte Nikolic, Michael W Neeson, Shane White, Gavin Marx, Robyn Cheuk, Michelle Grogan, Maria Farrell, Jessica Foudoulis, Paul J Neeson, Sherene Loi

2026-07-27

Pre-clinical evidence suggests that stereotactic ablative body radiotherapy (SABR) can enhance systemic anti-tumor responses when ..

Motherhood’s immune legacy reshapes the breast for lasting cancer defence

P Savas, B Virassamy, M Harris, S Loi

2026-01-01